EIKONOKLASTES THERAPEUTICS, INC.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Oct 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jul 29, 2025 · D | Oct 6, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $15,764,780 | $18,638,880 | $2,874,100 |
| Reported amount sold | $13,555,109 | $16,055,106 | $2,499,997 |
| Reported investor count | — | 15 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001805698-25-000002 · Later SEC source: 0001805698-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $18,638,880
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $16,055,106
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001805698-26-000001D/A · Oct 6, 2026 · PharmaceuticalsOffering: $18,638,880Sold: $16,055,106
Compared with 0001805698-25-000002:
- Reported offering amount: $15,764,780 → $18,638,880
- Reported amount sold: $13,555,109 → $16,055,106
- Reported investor count: Unavailable → 15
-
0001805698-25-000002D · Jul 29, 2025 · PharmaceuticalsOffering: $15,764,780Sold: $13,555,109